Very pleased to be representing @ISPORorg at the @ICHOM2023 conference in Barcelona. 650 delegates from 46 countries attending the conference to share and learn about the important work being done by @ICHOM_ORG in developing core outcome sets.
Brian O'Rourke retweeted
In the latest @ISPORJournals Value & Outcomes Spotlight @ORourke_B & I talk about the 2022 @ISPORorg Payer Summit & report on key findings
Big thanks to Carole Longson, @PeterNeumann11, @IgaLipska, & Alan Balch for their presentations
#HTA #Payers #PBMs
ispor.org/publications/journ…
Atttending the Women in HEOR session at #ISPOREurope Very proud to wear my ribbon signifying me as a Cool Guy Ally to Women in HEOR.
6
Second plenary at #ISPOREurope is focused on real world use of patient-centred research, with a description of the Darwin EU initiative from the @EMA_News Many questions arise with Darwin, including whether it will be used to support both regulatory and reimbursement decisions.
#ISPOREurope “Its the evidence stupid!” Great quote from @IgaLipska during the opening plenary of ISPOR Europe 2022.
Brian O'Rourke retweeted
Thank you to all of the participants of the 2022 ISPOR Health Technology Assessment Roundtable - Europe for an engaging and fruitful dialogue! Special thanks to the Chairs for their exceptional leadership and the speakers for their insightful presentations. #ISPOREurope #HTA
#ISPOREurope “Medical innovation only matters when it reaches the patient” says Emer Cooke from @EMA_News
Brian O'Rourke retweeted
It’s the 71st annual CMHA Mental Health Week!
Please read this important message from the CAF Surgeon General: canada.ca/en/department-nati…
Also, keep your eyes on the @CFHSvcs account for content throughout the week.
#CMHW2022 #GetReal #MentalHealth #WellBeing
Brian O'Rourke retweeted
Announcing the release of the INAHTA Position Statement on Disruptive Technologies! This statement reflects members’ views on the concept of disruptive technologies – a topic of significant interest amongst the INAHTA membership. View full statement here: https://xitter.gq/t.co/XSZwvGkqnf
Brian O'Rourke retweeted
Hey, fellow @ISPORorg members! It’s time to vote for your next president! Here’s a little video message from me about this election & videos from each of our two brilliant candidates: @jasminepwu and @ORourke_B
⬇️
ispor.org/about/our-leaders/…
The ballot is now open, so VOTE!!🗳️
Brian O'Rourke retweeted
Plenary 1: Rui Santos Ivo of @INFARMED_IP discusses an integrated approach and areas of action in scientific and regulatory advice including promoting timely access to medicines that introduce added value at a fair price, sustainable to NHS. #ISPOREurope #HTA
During the opening plenary at #ISPOREurope Dr. Hans-Georg Eichler stated that drugs with a small effect size and a small target population will have unavoidable uncertainty and that conventional HTA approaches will not be feasible. @ISPORorg
Opening plenary at #ISPOREurope Dr. Jo De Cock from INAMI Belgium describing a multi-stakeholder, international payer led initiative called RWE4Decisions. A key point mentioned by Dr. De Cock is that Outcomes-based MEAs should contain a clear RWE generation plan. @ISPORorg
Brian O'Rourke retweeted
ISPOR is thinking about many things, states @NbergBerg, including: Effectively communicating the value of #HEOR. Supporting #payers & decision makers. Digital transformation of #healthcare. Aligning HEOR and #technology. And more! #ISPOREurope
Up at 5:00 AM to listen to the opening plenary of #ISPOREurope Looking forward to hearing from moderator Dr. Guido Rasi and the panelists.
2
5
Brian O'Rourke retweeted
INAHTA and @HTAiOrg have renewed their Memoranda of Understanding, continuing a long & valuable relationship. The MOU, originally signed in 2008, was renewed in 2021 ensuring that MOU activities are ready for the future of HTA. Thank you HTAi, for being a great MOU partner!
Brian O'Rourke retweeted
Announcing the release of the INAHTA Position Statement on Patient Involvement ! This statement reflects INAHTA members’ views on the role of patient involvement in #HTA. View full statement here: https://xitter.gq/t.co/XSZwvGkqnf #patientinvolvement
Brian O'Rourke retweeted
Dark day for FDA. Approving a drug on the basis of post-hoc analysis of a failed trial, in the context of a 2nd failed trial, a worrisome safety signal, and an exorbitant price. Promoting false hope for Alzheimer’s is not in the best interest of patients nytimes.com/2021/06/07/healt…
Brian O'Rourke retweeted
‼️ #CADTHSymp: Now Accepting Call for Abstracts
Relevant topics:
- Uncertainty in #HealthPolicy and #HealthCare delivery
- Unconscious bias in health research
- Real-world evidence #RWE
- Drugs #RareDiseases
++
Submission Deadline: June 22 2021
cadth.info/3puTDpE
#HTA
















